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ARTICLE
Discovery of Salmonella trehalose phospholipids
reveals functional convergence with mycobacteria
Peter Reinink1,2*, Jeffrey Buter2*, Vivek K. Mishra3, Eri Ishikawa4,5, Tan-Yun Cheng2, Peter T.J. Willemsen6, Steffen Porwollik7,
Patrick J. Brennan2, Eva Heinz8, Jacob A. Mayfield2, Gordon Dougan8, Ce´cile A. van Els9, Vincenzo Cerundolo10, Giorgio Napolitani10,
Sho Yamasaki4,5, Adriaan J. Minnaard3, Michael McClelland7, D. Branch Moody2, and Ildiko Van Rhijn1,2
Salmonella species are among the world’s most prevalent pathogens. Because the cell wall interfaces with the host, we
designed a lipidomics approach to reveal pathogen-specific cell wall compounds. Among the molecules differentially expressed
between Salmonella Paratyphi and S. Typhi, we focused on lipids that are enriched in S. Typhi, because it causes typhoid
fever. We discovered a previously unknown family of trehalose phospholipids, 6,69-diphosphatidyltrehalose (diPT) and 6-
phosphatidyltrehalose (PT). Cardiolipin synthase B (ClsB) is essential for PT and diPT but not for cardiolipin biosynthesis.
Chemotyping outperformed clsB homology analysis in evaluating synthesis of diPT. DiPT is restricted to a subset of Gram-
negative bacteria: large amounts are produced by S. Typhi, lower amounts by other pathogens, and variable amounts by
Escherichia coli strains. DiPT activates Mincle, a macrophage activating receptor that also recognizes mycobacterial cord factor
(6,69-trehalose dimycolate). Thus, Gram-negative bacteria show convergent function with mycobacteria. Overall, we
discovered a previously unknown immunostimulant that is selectively expressed among medically important bacterial species.
Introduction
Salmonella enterica enterica Typhi (S. Typhi) is the etiologic agent
of typhoid fever. This enteric fever has a high mortality rate if
untreated and is responsible for ∼200,000 deaths annually
(Mogasale et al., 2014). More generally, diarrheal diseases from
Gram-negative bacteria are among the most prevalent and most
deadly bacterial infectious diseases in the world, comparable to
Mycobacterium tuberculosis, which causes tuberculosis (World
Health Organization, 2018). S. Typhi lives in a membrane-
bound vacuole, which does not fuse with lysosomes and per-
mits the intracellular replication of the bacteria. Gram-negative
bacterial cell walls are composed of an inner membrane domi-
nated by phospholipids, a thin layer of peptidoglycan polymer,
and an outer membrane with more complex lipids, which di-
rectly interface with the host.
Like other Gram-negative bacteria, Salmonella species syn-
thesize LPS, which resides in the outer leaflet of the outer
membrane and strongly stimulates the innate immune system
by triggering TLR4 (Poltorak et al., 1998). LPS is among the most
studied molecules in infectious diseases (Nature Reviews
Immunology, 2011), where it unquestionably controls fever
and sepsis as key manifestations of S. Typhi and other Gram-
negative bacterial syndromes. However, anti-LPS therapies have
had limited success in treating sepsis, and differing LPS che-
motypes do not fully explain the markedly different immuno-
genicity, fever-inducing capacity, and pathogenicity of diverse
Gram-negative bacterial species and strains. Further, given the
focus on LPS as a strong stimulant for the mammalian immune
system, the many other foreign molecules in Gram-negative cell
walls have received less attention. To our knowledge, compar-
ative lipidomic analyses of important pathogenic and non-
pathogenic Gram-negative species have not been reported,
raising the possibility that undiscovered virulence-associated
lipids exist.
To test this hypothesis, we recently developed a rapidmethod
that takes advantage of normal-phase chromatography to sepa-
rate and analyze dozens of classes and thousands of molecular
species of bacterial lipids by mass spectrometry (MS; Layre
et al., 2011). Combined with manual methods of TLC collision-
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induced dissociation MS (CID-MS) and nuclear magnetic re-
sonance (NMR) spectroscopy, this system has been proven to
offer an approach to discovery of previously unknown or
pathogen-specific lipids, such as phosphomycoketides, dideoxy-
mycobactins, and tuberculosinyladenosines (Matsunaga et al.,
2004; Madigan et al., 2012; Layre et al., 2014). Using S. Typhi
as an example of a major Gram-negative pathogen, we compared
its lipids to those of less pathogenic serovars including S. Para-
typhi, S. Enteritidis, and S. Typhimurium, generating clear evi-
dence for strain-specific differences in lipid synthesis.
Focusing on the most abundant lipids that are selectively
expressed by key pathogenic species, we discovered the prod-
ucts and defined the key genes of a new glycolipid biosynthesis
pathway in a subset of pathogenic Gram-negative bacteria. We
found that a gene product annotated as a cardiolipin (CL) syn-
thase B (ClsB) functions as the essential enzyme for an abundant
family of previously unknown immunogenic trehalose-containing
phospholipids. Whereas most phylogenetic analyses and clinical
strain typing rely on genetic methods, these studies illustrate the
unique information available through systematic analysis of
bacterial lipids. Similarities among mycobacterial and Salmonella
trehalose-containing lipids suggest functional convergence in
their activation of human immune response, highlighting a new
pathway to adjuvant development.
Results
Lipidomic analysis of pathogenic Salmonella serovars
We used HPLC-MS–based comparative lipidomics (Layre et al.,
2011) to study a major pathogenic S. enterica serovar, S. Typhi,
and compare its lipid profile with the less virulent but closely
related serovar, S. Paratyphi A. Each molecular species of lipid
isolated from the bacteria, or its adduct, is detected as a three-
component data point known as a molecular event. A molecular
event consists of a retention time on the HPLC column, a mass-
to-charge ratio (m/z), and an intensity value. The number of
molecular events estimates the total number of lipids present,
including chain length variants, altered adducts, and isotopes of
each molecule. The two Salmonella serovars combined generated
4,569 molecular events (Fig. 1 a). As expected, molecular di-
versity is lower than the 6,000–10,000 events in the highly
complex cell wall ofM. tuberculosis (Layre et al., 2011). However,
this number still represents substantial lipid diversity in a
Gram-negative pathogen. Comparison of S. Typhi and S. Para-
typhi A resulted in 865 lipids that differed in intensity by two-
fold with a corrected P value of <0.05, documenting substantial
divergence of the two lipidomes. This number exceeded our
experimental throughput for compound identification, so we
designed strategies to prioritize the unknown compounds for
identification.
Two previously unidentified, abundant lipids
To focus on lipids of high biological interest, including previ-
ously unknown compounds or candidate virulence factors, we
prioritized molecular events that (1) were enriched in S. Typhi,
(2) had high absolute intensity, and (3) had m/z values that did
not match known compounds in LIPID MAPS or other databases
(Fahy et al., 2009; Layre and Moody, 2013). Strain-specific en-
richment of two abundant lipids was evident even by relatively
insensitive normal-phase TLC method (Fig. 1 b). Two spots with
retardation factors (Rf) of 0.26 and 0.22 showed much denser
spots in S. Typhi as compared with S. Paratyphi A. Positive mode
nanoelectrospray ionization (nano-ESI) MS analysis of TLC
scrapings of these spots yielded spectra that were dominated by
ions of m/z 1,694.2 and 1,029.6, respectively. These were seen
along with ions corresponding to chain length and saturation
variants that differed by 14 (CH2) or 12 (C) u, including m/z
1,722.2, m/z 1,057.6, and m/z 1,069.5 (Fig. 1 c). Initial discovery
efforts emphasized HPLC time of flight (TOF) MS over TLC,
because the former is ≈ 106-fold more sensitive. That these two
lipids were visible by the less sensitive technique suggests high
abundance in S. Typhi (Fig. 1 b). Other lipids identified by the
HPLC-lipidomics system are produced at <10 parts per million
(ppm) of total cellular lipid (Moody et al., 2000, 2004). The limit
of detection of charring on TLC is ∼1 µg, so any clearly visible
spot in a profile from 300 µg of total bacterial lipid suggests
production in the low parts per hundred range. If the combined
density of the two unknowns is one fourth or more of that of the
phosphatidylglycerol (PG) standard (40 µg), these two unknown
lipids would comprise ∼3.3% of total extractable lipids of S.
Typhi (Fig. 1 b).
As a first step to identification, we sought to match low mass
accuracy values from TLC-nano-ESI MS (Fig. 1 c) to high mass
resolution data from the HPLC-TOF-MS lipidomic data ex-
pressed as a volcano plot (Fig. 1 a) or scatter plot (Fig. 1 d). This
approach identified ions corresponding to ammoniated adducts
([M+NH4]+) of M in the spectrum from the lipid with Rf 0.22 on
TLC (Fig. 1 c). Using the higher mass accuracy data (m/z
1,002.612), we deduced M as likely being C48H89O18P. This sug-
gested that the compound was a phospholipid, consistent with
its observed retention time in HPLC-MS (Fig. 1 e; 29.5 min)
matching known phosphoglycolipids (Layre et al., 2011). High
accuracymass value andmolecular formula allowed searching of
lipid databases, which returned no matches, suggesting that the
target was previously unknown. Given that S. Typhi is a widely
studied pathogen of worldwide significance, finding a previously
unidentified compound among the most abundant lipids in this
organism was unexpected. These data provided a strong ratio-
nale for focused analysis of the compounds of Rf 0.22 and 0.26 to
determine their complete structures.
Serovar-specific patterns of expression
Differential analysis of four pathogenic S. enterica serovars (S.
Typhi, S. Paratyphi, S. Enteritidis, and S. Typhimurium) using
three separately obtained clinical isolates within each serovar,
suggested uniform abundance of the two unknown lipids among
independent clinical isolates (Fig. 1 b). Looking across the sero-
vars, the two lipids showed the same ranking with S. Typhi > S.
Typhimurium ≈ S. Enteritidis > S. Paratyphi. These findings
were consistent with the possibility of coregulation of two
structurally related lipids in the same pathway. TLC (Fig. 1 b)
resulted in barely discernable bands in S. Paratyphi. How-
ever, using the established strains S. Typhi Quailes and S.
Paratyphi A strain NVGH308, ion chromatograms reproducibly
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demonstrated a coeluting lipid with a mass of 1,002.612 in
S. Paratyphi A, confirming the presence of trace amounts of the
unknown in this serovar (Fig. 1 e). Based on ion chromatogram
intensity calculated as peak area, S. Paratyphi produces ≈ ninefold
less product than S. Typhi. Overall, these data demonstrated
serovar-specific synthesis of many lipids in Salmonella and
identified two previously unknown phospholipids enriched in
S. Typhi.
Discovery of two trehalose phospholipids
Nearly all MS signals from TLC-purified S. Typhi material cor-
responded to m/z 1,694.2 or m/z 1,029.6 and the identifiable
isotopes and chain length variants thereof, suggesting each spot
contained only one major product (Fig. 1 b). Initial characteri-
zation by ion trap CID-MS tentatively identified the lipids as two
structurally related dihexose phospholipids that contained ei-
ther one or two phosphatidyl groups (Figs. 2 a and S1). The lower
band consisted of phosphatidyldihexose and the upper band
of diphosphatidyldihexose. One of the fatty acids in the phos-
phatidyl group was a palmitic acid (C16). The other one was a
C17:1, suggesting the presence of either an unsaturation or a
cyclopropyl group.
Because CID-MS cannot unequivocally identify the particular
hexoses or differentiate an unsaturation from a cyclopropyl
Figure 1. Detection of two unknown lipids in
Salmonella. (a) Three independent cultures of S.
Typhi (Quailes) and S. Paratyphi A (NVGH308)
underwent lipid extractions and comparative
lipidomics. Among all 4,569 molecular events
(black and gray circles), 865 (black circles) show
twofold intensity change (P < 0.05, corrected for
multiple comparisons). (b) Total lipid extracts
(300 µg/lane) of 12 independently derived clini-
cal isolates belonging to four different strains of
S. enterica entericawere analyzed by TLC. PG (40
µg) was used as a standard. Green boxes are
drawn around two unknown lipids with Rf 0.22
and Rf 0.26. (c) After isolation of the two un-
known lipids from S. Typhi from a water-sprayed
TLC plate (not shown), part of the isolated ma-
terial was reapplied on a TLC plate and charred
for analysis, and part was analyzed by positive
mode nano-ESI-MS. (d) Mean intensities (inte-
grated counts) of 4,569 ions detected in three
replicates of S. Typhi (Quailes) and S. Paratyphi A
(NVGH308) in a lipidomics experiment are
shown in a scatter plot with red dots corre-
sponding to ions matching the ammonium ad-
duct of M corresponding to the lipid with Rf 0.22
(m/z 1002.612) and its isotopes. (e) Extracted ion
chromatograms of the Rf 0.22 lipid for three in-
dependent cultures of S. Typhi and three S.
Paratyphi A measured at m/z 1,002.6.
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group in the C17 fatty acid, we undertook one- and two-
dimensional NMR spectroscopy analysis (Fig. 2 b and Dataset 1).
This approach showed that the lower migrating unknown com-
pound possesses two anomeric protons (doublets at δ 5.10 and 5.11
ppm) both with a coupling constant (J) of 3.7 Hz, suggesting an
α,α-linked dihexose structure (Roslund et al., 2008). The signals
between δ 3.3 and 4.1 ppmwere complex, necessitating correlation
spectroscopy (COSY) analysis, which allowed assignment of the
protons at C1–C5, showing two C5 signals at δ 3.82 and δ 3.95
(Dataset 1 b). Two-dimensional total correlation spectroscopy
(TOCSY)NMR (Gheysen et al., 2008) showed a one-spin system for
the dihexose unit with five cross-peaks and the anomeric center,
revealing the C6 signal at δ 4.08 (Dataset 1 c). Distortionless en-
hancement by polarization transfer heteronuclear single quantum
coherence spectroscopy (135DEPT-HSQC; Dataset 1 d) showed clear
C6 signals at δ 4.08 + δ 4.02 (with 13C = δ 65.6), and C69 signals at δ
3.79 + δ 3.67 (with 13C = δ 62.3). Also, an additional C4 signal could
be assigned at δ 3.36–71.7. The significant difference of the C6-
signals in both the 1H and 13C-NMR resulted from a phosphate
moiety at C6, as shown in the 31P-decoupled 1H-NMR (Fig. S2 e) and
the CID-MS spectrum (Fig. 2 a). Coupling constants for the dihexose
CH units were established to be in the 8- to 10-Hz interval, con-
sistent with J-values for trans stereochemistry. The only hexose
with all-trans stereochemistry between the H-atoms is glucose.
Figure 2. Structure elucidation of two trehalose phospholipids. (a) Partial structural elucidation of two unknown S. Typhi lipids based on nano-ESI-CID-
MSn illustrate the component structures (Fig. S1), which tentatively identify a dihexose core structures with likely phosphatidyl groups with C16 and C17:1 fatty
acyl units. (b) Interpretation of NMR spectroscopic data (Dataset 1) indicates the presence of two glucose groups in α-anomeric linkage and carriage of the
phosphatidyl groups at the 6-position of glucose, as well as cis-cyclopropyl groups in the fatty acyl units. The chain length position was not established directly
but corresponds to known structures. (c) High mass resolution CID-TOF-MS confirms key fragments seen in nano-ESI CID-MS (a), allowing chemical as-
signment of fragments with high reliability.
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Finally, the α,α-trehalose-6-phosphate moiety was unam-
biguously verified by comparing the 1H- and 13C-NMR signals
with that of α,α-trehalose-6-phosphate (Wang and Hollingsworth,
1995). The signals at δ 5.24 (m, 1H) and δ 4.00 (t, J = 5.6, 2H) and
the diastereotopic protons at δ 4.45 (dd, J = 3.0, 12.0, 1H) and δ
4.20 (dd, J = 6.9, 12.0, 1H) were part of one spin system in two-
dimensional TOCSY, consistent with a glycerol moiety (Pe´rez-
Victoria et al., 2009). 1H-NMR signals with resonances at δ
−0.32, 0.60, and 0.68 ppm strongly suggested a cis-cyclopropane
unit (Knothe, 2006). NMR spectra from the higher migrating
unknown were similar to those described above (Dataset 1, f–i)
but were less complex because of reduced peak overlap, consis-
tent with a symmetrical molecule.
The presence, but not the location and absolute stereo-
chemistry, of the cyclopropyl group was established experi-
mentally. Prior analyses of C17 fatty acids in the closely related
species Escherichia coli suggest that cyclopropyl groups occur at
the 9,10 position (Grogan and Cronan, 1997) and are enriched on
the SN2 fatty acyl unit (Hildebrand and Law, 1964), which is
consistent with our data. Extending the low mass accuracy re-
sults of nano-ESI-CID-MS, TOF CID-MS (Fig. 2 c) yielded high
mass accuracy ions that enabled determination of the atomic
composition of the fragments (Fig. 2 c), solving the structures of
the unknowns as 6-phosphatidyltrehalose (PT) and 6,69-di-
phosphatidyltrehalose (diPT). To our knowledge, this is the first
report of trehalose-containing phospholipids.
Next, we sought to determine if the weaker coeluting bands
detected in other Salmonella serovars (Fig. 1 b) represented
chemically identical molecules. Despite being available in lower
quantity and purity, NMR patterns of TLC-purified material
from S. Typhimurium and S. Enteritidis were consistent with
the lipids from each of these three serovars being chemically
identical (Fig. S2 a). Although the lower yields limited NMR
analysis and introduced artifacts from water contamination,
CID-MS allows specific targeting of ions matching the m/z of
PT and diPT. CID-MS independently established all of the
major components of these structures, including fragment
ions matching m/z values for loss of hexose, loss of dihexose,
loss of phosphatidylhexose, and mono- and diacylated phos-
phatidyl units (Fig. S2 b). Also, S. Typhimurium and S. En-
teritidis lipids coeluted with S. Typhi lipids as the characteristic
doublets, matching the retention of TLC-MS–proven PT and diPT
(Fig. 1 b). The combined TLC, MS, and NMR analyses provide
clear evidence for production of PT and diPT by all three
species.
Synthesis of diPT
Trehalose is an abundant and common disaccharide in plants
and certain bacteria but is rare or absent in mammalian cells.
Therefore, trehalose-containing lipids are by definition foreign
compounds for the mammalian immune system. M. tuberculosis
produces a highly immunogenic trehalose-containing glycolipid,
first known as cord factor and later elucidated as 6,69-trehalose
dimycolate (TDM; Adam et al., 1967). TDM is one of the most
widely used adjuvants in vaccines and experimental medicine.
TDM can be administered as complete Freund’s adjuvant, where
TDM is a major, but not the only, immune stimulus (Geisel et al.,
2005; Shenderov et al., 2013), as pure TDM, or the simplified
structure 6,69-trehalose dibehenate (Pimm et al., 1979; Holten-
Andersen et al., 2004). A major pathway of macrophage acti-
vation and enhancement of adaptive immune responses
by TDM is via the pattern recognition receptor macrophage
inducible C-type lectin (Mincle [or Clec4E]; Ishikawa et al.,
2009; Werninghaus et al., 2009). Mincle is a member of
the C-type lectin superfamily expressed on macrophages and
other myeloid cells.
These considerations provided a strong rationale to test for
immune responses to these newly discovered trehalose-based
compounds. However, even though MS and NMR spectroscopy
suggested high purity of TLC-purified trehalose phospholipids,
S. Typhi synthesizes LPS, which is bioactive at picomolar con-
centrations. As LPS or other minor contaminants could create
false-positive results in cellular assays, we undertook the com-
plete chemical synthesis of diPT. Based on prior reports de-
scribing naturally occurring Gram-negative bacterial fatty acids
(Hildebrand and Law, 1964; Grogan and Cronan, 1997), we first
synthesized 9R,10S cyclopropyl fatty acid. This compound, to-
gether with palmitic acid, was used to prepare the required di-
acylglycerol, which along with hexabenzyl trehalose were used
to assemble diPT via phosphoramidite coupling and subsequent
deprotection. The nine-step synthesis was performed with an
overall yield of 69%, resulting in 15 mg of the final product. The
final product was validated by HPLC-MS and NMR spectroscopy
showing good correspondence of the chemical shifts between
the two samples, thereby verifying the proposed chemical
structure of diPT (Fig. S3 vs. Dataset 1, f–j).
Access to milligram quantities of a synthetic diPT standard
allowed more quantitative assessments of diPT as a component
of the S. Typhi lipidome (Dataset 1 k). Using synthetic diPT as an
internal standard for HPLC-MS and applying the method of
standard additions to the three brightest natural diPT ions, we
estimate that diPT is 2.5% of S. Typhi total lipid extract. This is a
conservative estimate, because more than six ions are seen, and
it generally matches the estimate for diPT of 1.7% derived from
TLC (Fig. 1 b). Both results indicate that diPT and PT are among
the most abundant lipids in S. Typhi.
S. Typhi trehalose phospholipids are potent Mincle ligands
The overall chemical resemblance between diPT and TDM is that
both are symmetrical molecules with a trehalose core that is
substituted with lipids attached at the two 6-positions (Fig. 3 b).
The key difference is that diPT is substituted with phospholi-
pids, whereas TDM is substituted with mycolic acids. To deter-
mine whether diPT is recognized by Mincle, we used a reporter
cell line stably transduced with murine Mincle, its signaling
partner, FcRγ , and an NF-κB–driven GFP reporter construct.
Because hydrophobic glycolipids like TDM are integrated in
membranes and do not act in solution, bioassays to mimic this
interaction rely on first coating wells with lipid and then adding
cells in aqueous media. Despite this technical limitation, dose
responses are measurable (Fig. 3 c). The dose responses to TDM
and natural diPT were similar and highly sensitive in absolute
terms, with cells responding to 5 ng of coated lipid. Pure syn-
thetic diPT was less potent but still recognized in low amounts,
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with responses seen at 20 ng of coated lipid. Although the potent
stimulation of reporter cells by synthetic diPT rules out effects of
LPS or other trace bacterial contaminants as mediating response
to natural diPT, the reduced GFP signal at high doses of natural
diPT could reflect LPS-mediated toxicity. Synthetic sulfoglyco-
lipid (James et al., 2018), a glycolipid substituted at the 2 and 3
positions of trehalose, did not stimulate the Mincle reporter cell
line at high doses. Subsequently, we compared murine and
human Mincle reporter cell lines and again found highly sen-
sitive responses to synthetic diPT, with activation present at
nanogram levels. Human Mincle is marginally more sensitive to
diPT than to TDM, while for murine Mincle, the opposite is true
(Fig. 3 d). DiPT failed to activate a negative control cell line
expressing FcRγ only. Thus, diPT efficiently stimulates Mincle.
Figure 3. Synthetic diPT is a high potency Mincle agonist. (a) Schematic representation of the chemical synthesis of diPT containing C17:1 and C16 fatty
acyl units such as found in natural diPT. (b) For comparison, chemical structures of the two natural trehalose based lipids, the known Mincle ligand, M.
tuberculosis TDM and diacylated sulfoglycolipid (Ac2SGL). (c) GFP expression was measured using a murine Mincle-FcRγ reporter cell line and the indicated
plate bound lipids (nanograms per well) in singlicate. Data are representative of five experiments using different combinations and dose of antigens with similar
results. (d) GFP expression of reporter cell lines expressing murine Mincle-FcRγ, human Mincle-FcRγ, or FcRγ alone after stimulation with TDM or synthetic
diPT in triplicate wells. Error bars represent standard error of the mean. P < 0.001 by ANOVA after curve fitting and analysis using the R package drc.
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Candidate gene approach to biosynthesis
To determine the mechanism of biosynthesis of trehalose
phospholipids, we used a candidate gene approach. DiPT was
previously unknown, and we could not identify substantially
similar lipids in other bacteria that could point us toward can-
didate synthetic enzymes involved in phospholipid transfer onto
trehalose. However, genes for biosynthesis of the two compo-
nents of diPT, trehalose and PG, are well known, as are those
enzymes that produce “substituted PGs” like phosphatidylino-
sitol and CL. Considering PT and diPT as carbohydrate-substituted
PG and mining the S. Typhi genome, we identified 12 candidate
genes for biosynthesis. Among these 12 candidates are four bio-
synthetic enzymes that produce trehalose from either glucose
6-phosphate and UDP-glucose (OtsA and OtsB) or from α(1–4)-
linked glucose polymers (TreY and TreZ). A fifth enzyme shares a
domain with PapA3, which is responsible for lipid transfer onto
mycobacterial trehalose phleate (EntF; Burbaud et al., 2016). In
addition, we tested four enzymes involved in synthesis of phos-
pholipids (PagP, PgpA, PgpB, and PgpC) and three putative CL
synthases (ClsA, ClsB, and ClsC), which are thought to transfer
phosphatidyl units onto PG.
Clsb is essential for trehalose phospholipids, but not CL
We tested 12 candidate diPT and PT biosynthetic genes using two
sets of single gene knockouts in S. Typhimurium, which were
generated independently as kanamycin or chloramphenicol se-
lected mutants (Porwollik et al., 2014). Because diPT did not
resolvewell on normal-phaseHPLC-MS,we developed a suitable
reverse-phase HPLC method that could reliably detect both PT
and diPT. An equivalent mass of total lipid, as determined by
weighing dry lipid, from each single gene knockout (Fig. 4 a) was
analyzed using phosphatidylethanolamine (PE) as a secondary
loading control (Table S1). This screen provided a clear result
that was reproducible in both sets of mutants and for both lipids,
with essentially all or nothing effects for each gene studied. Of 12
candidates, 11 genes (aas, clsA, entF, otsA, ostB, pagP, pgpA, pgpB,
pgpC, treY, and treZ) were nonessential for biosynthesis (Fig. 4
a). There was no trehalose in the culture media, yet trehalose
phospholipids persisted in single gene knockouts in trehalose
biosynthesis pathways. This outcome likely resulted from the
existence of independent routes to trehalose production, which
involve either glucose-6-phosphate (OtsA and OtsB) or maltose
and maltodextran (TreY, TreZ, TreT, and TreS) intermediates.
Only the clsB single gene knockout showed loss of PT and diPT in
both mutant sets, while PE levels were unchanged (Fig. 4, a and
b; Table S1). That this loss of PT and diPT was observed in two
independently generated single gene knockout sets reduces the
likelihood that lipid loss was due to an unrelated second hit
occurring elsewhere in the genome of clsB mutants. Even so, we
genetically complemented a clsB knockout using an arabinose-
inducible system. Only when treated with arabinose, the re-
constituted clsB knockout (ΔclsB::clsB) produced PT and diPT,
demonstrating that clsB is necessary and sufficient for its pro-
duction (Fig. 4 c). In theWT strain, arabinose treatment partially
diminished diPT synthesis for unknown reasons, which might
partly explain why the arabinose-treated, genetically com-
plemented strains did not fully restore lipid production to WT
levels. Taken together, these data point to ClsB as an essential
enzyme for the synthesis of trehalose phospholipids.
The acronym clsB (previously known as ybhO or f413) stands
for CL synthase B (Guo and Tropp, 2000), an assignment based
on sequence homology rather than direct demonstration of this
enzymatic role. Using HPLC-MS to detect signals (m/z 1,390) at
the retention time of a CL standard, we observed no significant
change in the intensity or shape of the biphasic peak assigned to
CL in the clsB knockouts (Fig. 4 d and Table S1). We conclude that
clsB is nonessential and, under the conditions tested, does not
affect CL concentration. Although an adjunctive role in CL bio-
synthesis might be masked by parallel functions of ClsA and
ClsC, the simplest interpretation is that ClsB is, despite its name,
not a CL synthase. Instead of coupling phosphatidic acid to PG,
ClsB could couple phosphatidic acid to trehalose. Consistent with
this interpretation, previous work has also suggested the likely
existence of an unknown substrate for ClsB (Tan et al., 2012; Li
et al., 2016) and that ClsA or ClsC is sufficient for CL synthesis.
The clsB knockout strain represented a new tool to determine
if diPT and PT, considered among all cell wall lipids, were es-
sential to stimulate Mincle. First, we found that total lipid ex-
tract from WT S. Typhimurium stimulated Mincle (Fig. 4 e).
Although lower Mincle reporter response was seen compared
with using pure diPT, this outcome was expected based on the
much lower concentration of diPT among all lipids, the plate-
bound nature of the lipid presentation in this assay, and the
possible existence of antagonists or toxic factors among total cell
wall lipids. However, the total lipid extract from ΔclsB bacteria
did not stimulate human or murine Mincle reporter lines (Fig. 4
e), suggesting that among all lipids in S. Typhimurium, the diPT
pathway is the dominant or sole source of Mincle ligands.
Genetic and chemical phylogeny of clsB and diPT
After the initial identification of trehalose phospholipids in S.
Typhi, S. Typhimurium, S. Enteritidis, and S. Paratyphi, we next
asked how broadly distributed these compounds are among
bacteria. Also, given that PT and diPT were discovered in enteric
bacteria, the specific question arises as to whether humans are
continuously exposed to trehalose phospholipids via intestinal
microbiota or through infection with enteric pathogens. First,
we used a basic local alignment search tool (BLAST)–reverse
BLAST-based approach to ask whether a S. Typhi ClsB ortho-
logue is present in genomes of closely and distantly related
bacterial genera (Fig. 5, a and b). The four studied S. enterica
enterica strains had clsB genes predicted to encode proteins
that were 100% identical, and S. bongori encoded a 99%
identical protein. The genomes of species belonging to β- and
γ-proteobacterial Escherichia, Shigella, Pseudomonas, and Borde-
tella encoded ClsB proteins that ranged from 51% to 87% identity
to S. Typhi ClsB protein. We found no identifiable ClsB ortho-
logues among α- and ε-proteobacteria or among more distant
groups such as Gram-positive bacteria and actinobacteria. In all
bacterial species found to have a ClsB orthologue, a ClsA or-
thologue, which has an established role in CL synthesis, was also
present. Furthermore, phylogenetic analysis showed that ClsA,
ClsB, and ClsC form distinct monophyletic branches clearly
separating the three enzymes (Fig. 5 b).
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Figure 4. ClsB is necessary for the biosynthesis of PT and diPT. (a) Abundance of PT and diPT was determined in total lipid extracts from two inde-
pendently generated sets of S. Typhimurium single gene knockouts generated by selection under kanamycin (set 1) or chloramphenicol (set 2). (b) Extracted ion
chromatograms of PT (m/z 983.6) and diPT (m/z 1626) in lipid extracts fromWT S. Typhimurium and in S. Typhimurium ΔclsB. (c) PT and diPT production inWT
S. Typhimurium, S. Typhimurium ΔclsB mutant (ΔclsB), and genetically complemented S. Typhimurium ΔclsB (ΔclsB::clsB) in the presence or absence of the
inducer, arabinose. (d) Extracted ion chromatogram of CL in lipid extracts from WT S. Typhimurium and S. Typhimurium ΔclsB. The identity of CL was
confirmed by high-resolution MS, where the observed m/z 1,389.98 matches the expected mass of 1,389.981, and CID-MS, which identified fragments cor-
responding to phosphatidyl units and fatty acids. (e) Total lipids fromWT or ΔclsB S. Typhimurium were used to stimulate reporter cell lines expressing murine
Mincle-FcRγ, human Mincle-FcRγ, or FcRγ alone in triplicate wells. Error bars represent standard error of the mean. P < 0.001 by ANOVA after curve fitting and
analysis using the R package drc.
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Figure 5. PT and diPT in other bacterial strains. (a) Phylogenetic tree based on 16S RNA sequences of a broad range of bacterial species, focusing on close
relatives of Salmonella (inset). Species that underwent genomic analysis and lipid chemotyping are indicated by red triangles. (b) Phylogenetic tree of Cls
protein sequences. (c) HPLC-TOF-MS yielded extracted ion chromatograms matching the mass of PT and diPT for the indicated bacterial strains. (d) The amino
acid identity of the translated clsB genes to S. Typhi ClsB and results of HPLC-MS–based chemotyping for PT and diPT are summarized (+, detected; −, not
detected). (e) Extracted ion chromatograms corresponding to the mass of PT and diPT in lipid extracts of human fecal samples, samples of murine intestinal
content, and a positive control sample consisting of murine intestinal content prespiked with S. Typhi total lipid extract before processing. Results are
representative of 10 human and three mouse fecal samples, and positive signals would not be detected after increasing gain by 40- to 100-fold (insets).
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We next determined the extent to which such phylogenetic
comparisons using gene homology analysis correctly predict the
diPT and PT chemotypes. Therefore, we used HPLC-MS to che-
motype 16 broadly divergent species highlighted in the bio-
informatic analysis (Fig. 5, c and d). Despite high (99%) similarity
with the S. Typhi clsB gene, we did not detect diPT or PT in S.
bongori or in other species in which we found a clsB orthologue,
including Pseudomonas aeruginosa, Bordetella pertussis, and Shigella
species. Whether this is due to functional differences of the en-
zyme itself or instead to differences in its species-specific ex-
pression or interaction with other enzymes in the pathway will
require further detailed studies beyond the scope of this analysis.
A rather unexpected finding, pointing toward unknown contri-
bution of expression level or other interacting proteins, was the
distribution of diPT and PT among the six E. coli strains tested.
Despite identical culture conditions and identical coding regions
of their clsB genes, we found that four of the six strains synthe-
sized the compounds (clinical isolates CVI-7, CVI-19; laboratory
strains DH10B, BW25113), while two did not (ATCC25922, DH5α).
We conclude that having a clsB gene is required for the synthesis
of PT and diPT, but as-yet-unknown additional requirements, like
gene transcription or production of precursor molecules or the
lack of suppressors, must be met. In addition, genes annotated as
clsB, based on the full-length sequence, may not have equivalent
functionality because of small changes in key residues at the
catalytic site or other critical sites in the protein.
Our results pointed to diPT as a strain-specific phenotype
present in certain gastrointestinal pathogens, but the unexpected
detection of diPT in E. coli strains raised questions about its pos-
sible role in the intestinal microbiome. Although feces represents a
complex mixture of bacteria, E. coli is a common and abundant
species in human feces, and in vitro evidence for high trehalose
phospholipid production by this and other enteric bacteria raise
the question of whether this compound can be detected in stool.
Therefore, we looked for trehalose phospholipids in mouse and
human stool samples by HPLC-MS. Neither PT nor diPT was de-
tected in any of 10 human fecal samples, nor was it detected in
murine ileum, colon, or cecum contents. This result held true for
standard HPLC-MS readouts and also when signals were amplified
40- to 100-fold to assess the diPT signal at the limit of detection by
MS (Fig. 5 e). Because stool contains a multitude of bacteria and
fungi as well as partly digested food and host-derived material, we
considered possible false-negative results by cross-suppression
from unrelated compounds. However, separation by HPLC be-
fore ionization greatly reduces cross-suppression. A spike in pos-
itive control of an S. Typhi lipid extract containing an estimated
amount of 20 µg PT and diPT generated strong trehalose phos-
pholipid signals (Fig. 5 e). Thus, trehalose phospholipids appear to
be undetectable or absent from the normal intestinal microbiota.
Overall, these data indicate that production of diPT is a
strain- or serovar-specific phenotype and varies among isolates
of the same species. ClsB orthologue searches are not sufficient
to predict the presence of diPT, highlighting the usefulness of
lipid chemotyping assays. Further, these results reveal a general
pattern that diPT is restricted to a subset of Gram-negative
bacteria; it is found in pathogens, but not gastrointestinal flora
of healthy donors. Considering its role as an agonist for Mincle, a
widely expressed innate immune pattern recognition receptor
in humans, diPT becomes a candidate for adjuvant development,
control of virulence, and a new marker of clinical interest to
physicians.
Discussion
These data identify ClsB as essential for production of PT and diPT
in the major disease-causing serovars of S. enterica enterica. Al-
though trehalose is common in plants and bacteria, trehalose
phospholipids were previously unknown. Thus, the discovery and
detection of diPT and PT was entirely unexpected and prompts
the reconsideration of the function of the enzyme known as ClsB.
ClsA condenses two PG molecules to form CL, whereas ClsC
condenses PE and PG (Tan et al., 2012; Rossi et al., 2017). Despite
its name and homology to ClsA and ClsC, the function of ClsB has
been less clear. E. coli ClsB mediates PG turnover to CL outside of
cells, but in other experiments, it does not affect CL content in
E. coli (Guo and Tropp, 2000; Tan et al., 2012) or Shigella flexneri
(Rossi et al., 2017). Thus, it was previously suggested ClsB might
actually use different, unknown, substrates or produce lipids
other than CL (Tan et al., 2012), a hypothesis that is directly ruled
in by our data. Other members of the phospholipase D super-
family cleave phosphates to transfer phosphatidic acid to an ac-
ceptor, and here we show that S. Typhimurium clsB is absolutely
required for PT and diPT biosynthesis, suggesting that trehalose
could be an acceptor for phosphatidic acid transfer. While in vitro
studies of recombinant ClsB are required to test this hypothesis,
our findings cast further doubt on a gene function corresponding
to its name as a CL synthase.
Here, we identified murine and human Mincle as cellular
receptors for diPT. Members of the C-type lectin family of re-
ceptors, which also includes Dectin-1, Dectin-2, and DC-SIGN,
can activate monocytes, macrophages, and myeloid dendritic
cells via an immunoreceptor tyrosine-based activation motif
(ITAM) or ITAM-like domains that act as kinases to turn on
phospho-Syk signaling pathways (Del Fresno et al., 2018). The
crystal structure of human Mincle identifies a calcium-binding
site positioned near a proposed carbohydrate-binding site,
which in turn is located adjacent to a hydrophobic patch
(Feinberg et al., 2013; Furukawa et al., 2013). Mincle activation
occurs in response to 1-linked and 6-linked glucose–containing
lipids (Behler-Janbeck et al., 2016; Decout et al., 2017; Nagata
et al., 2017). Comparative analysis with other C-type lectins,
mutational analysis, and molecular modeling suggest that the
glucose or trehalose sugars common to natural Mincle ligands
bind in the carbohydrate-binding site (Feinberg et al., 2013;
Furukawa et al., 2013; So¨ldner et al., 2018). The 6,69-linked C20
fatty acids in trehalose dibehenate and C80 mycolic acids in
TDM are proposed to bind in the hydrophobic patch. Thus, diPT
contains the two key chemical elements previously proposed to
mediate Mincle binding. However, because there is no prece-
dent for Mincle activation by phospholipids, prior models have
not accounted for putative interactions with an anionic phos-
phoglycerol unit. There is no identifiable cationic binding site
between the carbohydrate-binding site and the hydrophobic
patch on Mincle. However, docking simulations suggest that the
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most proximal part of 6-linked alkyl chains, corresponding to
the two phosphoglycerol units in diPT, do not contact Mincle
(So¨ldner et al., 2018). Thus, existing models predict diPT dock-
ing in a manner in which the phosphate moieties act as a bridge
between the sugar- and lipid-binding epitopes, rather than di-
rectly contacting Mincle.
These structural considerations and the precedent of TDM
provide a rationale for adjuvant development using synthetic
modifications of the natural diPT structure. Freund’s adjuvant is
widely used in experimental biology and provided the basis for
use of pure TDM as an adjuvant. Subsequently, the chemically
simplified and more hydrophilic adjuvant 6,69-trehalose di-
behenate was developed as a further refinement of the TDM
natural structure (Pimm et al., 1979; Holten-Andersen et al.,
2004). Unlike these molecules, diPT contains two phospholipid
units, which further promote water solubility, a favorable fea-
ture in adjuvant development. This chemical consideration,
along with the high potency of synthetic diPT for human Mincle
agonism, supports further modification of the diPT chemical
scaffold for adjuvant development. In particular, the chemical
syntheses reported here for diPT can be modified to include
simplified lipid moieties to further increase water solubility
without affecting the Mincle-binding regions of the molecule.
Results from reporter lines rule in both human and mouse
Mincle as receptors for diPT. Conversely, the loss of Mincle
agonism in the clsB knockout strongly suggests other unrelated
compounds in S. Typhimurium do not redundantly agonize
Mincle. These data establish key receptor–ligand interactions,
raising new questions about the broader cell biology of macro-
phage response. For example, whether PT and diPT activate
other innate immune receptors is unknown, and the specific
subtypes of myeloid cells or macrophages activated by this
system are not yet understood. Although they are structurally
related and nearly equipotent, the extent to which Gram-
negative bacterial and mycobacterial agonists have equivalent
function is not yet known. The study of these new natural and
synthetic Mincle agonists can be used to test certain questions
and controversies that have arisen through study of mycobac-
terial cord factor, TDM (Ishikawa et al., 2009). In addition to
activatingMincle, cord factor has been reported to activate TLR4
and related MyD88-based signaling pathways (Geisel et al.,
2005; Oda et al., 2014). The phosphate moieties of PT and diPT
render these compounds as “phospholipid” variants of cord
factor. This and themono- versus divalent nature of PT and diPT
might influence the final outcomes of cellular activation.
TDM synthesis in M. tuberculosis takes place by transfer of
mycolic acids to the 6 and 69 positions of trehalose by the en-
zymes proteins Ag85A, Ag85B, and Ag85C (Belisle et al., 1997;
Backus et al., 2014). ClsB is not related to Ag85 proteins but is
instead a member of the phospholipase D family of proteins.
Therefore, the TDM and diPT-generating enzymes and the genes
that encode these enzymes are unrelated, but their products are
similar with regard to structure and function. Thus, the separate
evolution of differing enzymes that lead to molecules with
highly similar structure that trigger the same receptor might be
a previously unrecognized example of evolved functional con-
vergence of Gram-negative bacteria and mycobacteria.
Whereas prior work on Mincle has emphasized mycobacte-
rial and fungal ligands, the data presented here generate a strong
link with Gram-negative enteric bacteria. We demonstrate that
five serovars or strains of common Gram-negative bacteria
produce Mincle ligands. Further, although we do not yet know if
diPT has other functions, other lipids in S. Typhimurium cannot
substitute for ClsB-dependent lipids for Mincle activation. The
emerging serovar- and species-specific patterns of diPT pro-
duction suggest that diPT is likely restricted to Gram-negative
enteric bacteria. We failed to detect diPT in the enteric flora of
healthy humans and mice but instead detect the compound in
some E. coli strains and serovars of S. enterica enterica, with
highest expression in S. Typhi, which is the cause of typhoid
fever. These correlations between virulence and diPT expres-
sion support directed studies of diPT as a virulence factor. Given
the differential high, low, or absent levels of diPT within strains
or serovars of the same species, as well as the low predictive
value of ClsB gene identity for diPT, lipid chemotyping of clinical
samples will be needed to understand the role of diPT in infec-
tion. The high production of diPT by S. Typhi, its potent agonism
of a major activating receptor onmacrophages, and the presence
of diPT among bacteria that cause enteric fever syndromes now
raise a key question for future studies: Does diPT contribute to
fever and sepsis that define enteric fever syndromes?
The World Health Organization estimates that diarrheal
diseases, most commonly caused by enteric Gram-negative
pathogens, remain the ninth leading cause of death worldwide,
the fourth leading cause of death in developing nations,
and a major cause of death among children (World Health
Organization, 2018). Accordingly, S. Typhi and related sero-
vars are priority pathogens that have spurred development of
diagnostics, drug treatments, antisepsis regimens, and vaccines
(Andrews et al., 2019). Both clinical and basic research on Gram-
negative bacterial lipid endotoxins focuses on LPS–TLR4 inter-
actions, which is one of the most extensively studied and
widely recognized receptor–ligand pairs in immunology (Nature
Reviews Immunology, 2011). Given this high investment in LPS
and extensive attention to disease-causing serovars, it is striking
that two immunogenic lipids that are abundant in the most
virulent serovar could go undiscovered in decades of research on
Salmonella species. Here, we describe diPT as an immunogen
hiding in plain sight in bacterial membranes. This example
underscores that the membrane content of Gram-negative bac-
terial cell walls, particularly the complex glycolipids in the outer
membrane interfacing with the human host, remain an under-
studied resource for immunogens and virulence factors. The
lipidomic profiles reported here identify hundreds of molecular
species that differ by serovar, pointing to specific future paths
for detecting serovar-specific lipid markers, including other
molecules that could control host response.
Materials and methods
Bacterial cultures and total lipid extraction
In addition to the bacterial strains listed in Table S2, we used S.
Typhimurium 14028s strains in which single genes are replaced
by a cassette containing a kanamycin resistance gene oriented in
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the sense direction or a chloramphenicol resistance gene ori-
ented in the antisense direction (Porwollik et al., 2014). A single
colony was picked from a plate, transferred to a 3-ml starter
culture, and incubated overnight at 37°C while shaking. 1 ml of a
starter culture was added to 500 ml of medium and incubated
overnight at 37°C while shaking. Bacteria were centrifuged for
15 min at 3,500 rotations per minute and washed twice with
PBS. Lipid were extracted by rocking the pellet in organic sol-
vent for 1 h at 20°C, centrifugation for 10 min at 3,500 rotations
per minute, and collection of the supernatant. Solvents used for
extraction were HPLC grade 2:1 chloroform:methanol (C:M;
Merck), 1:1 C:M, and 1:2 C:M. The three supernatants were
pooled and dried and lipids were dissolved and stored in 1:1 C:M.
Murine colon, cecum, or small intestinal content (0.5–1.0 g) or
fresh human stool (1.0–2.0 g) was suspended in 10:1 CH3OH:
0.3% NaCl in water and subjected to a series of extractions
against petroleum ether, 9:10:3 CHCl3:CH3OH:0.3% NaCl in
water, and 5:10:4 CHCl3:CH3OH:0.3% NaCl in water. Extracts
were combined, dried, and weighed. Spiked samples were
spiked directly after initial suspension in 10:1 methanol:0.3%
NaCl in water.
Comparative lipidomics
Total lipid extracts of triplicate cultures of S. Typhi (Quailes) and
S. Paratyphi A (NVGH308) were separated using GL-Sciences
Inertsil Diol 3 µm 2.1 × 150 mm normal-phase HPLC column
equipped with Varian Monochrom 3 µm × 4.6 mm Diol guard
column. Lipids were measured on an Agilent Quadrupole Time-
of-Flight Accurate-Mass QTOF LC/MS G6520B instrument in
positive mode as described previously (Layre et al., 2011). Data
were analyzed using Mass Hunter (Agilent), LIMMA (Ritchie
et al., 2015), and XCMS (Smith et al., 2006).
TLC
DURASIL-25 TLC plates (Macherey-Nagel) were precleared with
C:M:H2O (60:30:6 [vol:vol:vol]) and dried. Bacterial total lipid
extract (300 µg) or purified standard (40 µg) were applied and
resolved with C:M:H2O (60:30:6 [vol:vol:vol]). The plates were
dried and either stained for analytical purposes (Fig. 1 b) or used
for specific lipid isolation. Staining was performed by spraying
3% copper acetate monohydrate (Sigma-Aldrich) in 8% phos-
phoric acid (Merck) on the plate and baking at 140°C. Isolation of
specific lipids was performed after spraying the plate with wa-
ter, which makes lipids bands temporarily visible. Lipids of in-
terest were marked, the plate was dried, and the silica layer
containing the lipid was scraped of the glass plate. The lipid was
isolated from the silica by rocking the silica for 1 h in 1:1 C:M.
After rocking, the sample was centrifuged and the supernatant
containing the lipid was stored. PE (850758P) and PG (840503P)
standards were from Avanti Lipids.
Analytical MS
For mass determination and higher-order CID-MS, purified
lipids were dissolved in methanol and measured by nano-ESI-
MS in the positive mode (LXQ Linear Ion Trap Mass Spec-
trometer with MSn software; Thermo Fisher Scientific). For
optimal detection and quantification of PT, diPT, pPE, and CL
with high mass resolution, reverse-phase HPLC-MS was per-
formed on an accurate-mass QTOF LC/MS G6520 instrument. In
15 min, a gradient from 100% solvent A (5% H2O in MeOH with
2 mM ammonium formate) to 100% solvent B (10% cyclohexane
in 1-propanol with 3 mM ammonium formate) was run on an
Agilent Poroshell 120A˚, EC-C18, 1.9 µm column equippedwith an
Agilent EC-C18, 3.0 × 5 mm, 2.7 µm guard column. The elution
time of CL was determined using a synthetic standard (750332;
Avanti). For the quantification of natural diPT, the standard
addition analytical method was used. S. Typhi total lipids (1 mg/
ml) were spiked with a series of known concentrations of syn-
thetic diPT (0, 5, 10, and 15 µg/ml) and subjected to reverse-
phase HPLC-MS analysis. The peak areas of extracted ion
chromatograms of m/z 1,626.032 (fatty acid chain length and
unsaturation: C66:2) were plotted against the concentrations of
the spiked synthetic standard. The extrapolated number on the
x axis is the estimated concentration of natural diPT (m/z
1,626.032) in the S. Typhi total lipid extract. The peak area of two
other fatty acid variants (m/z 1,654.064 C68:2 and m/z 1,648.016
C68:5) were also extracted and compared with the peak area of
m/z 1,626.032 to determine their concentrations. The estimated
natural diPT percentage was obtained by the combined con-
centrations of three major chain length analogues divided by the
total injected lipid concentration (1 mg/ml).
NMR
NMR spectra were recorded on an Oxford 600-MHz magnet
(600 MHz for 1H, 151 MHz for 13C) Bruker AVANCE II Console
system equipped with a 5-mm Prodigy HCN TXI cold probe and
an Agilent 700-MHz magnet (700 MHz for 1H, 176 MHz for 13C)
with a DDR2 console equipped with an Agilent triple-resonance
helium cold probe. The 31P-decoupling experiments were per-
formed on a Varian 400-MHz magnet equipped with a 5-mm
AutoX OneProbe. Chemical shifts are reported in ppm and
coupling constants (J) in Hz. The samples were measured in
MeOH-d4 of which the residual solvent resonance was used as
an internal standard (δ 3.31 for 1H, δ 49.00 for 13C). The 1H-NMR
spectra were assigned using COSY, TOCSY, multiplicity-edited
HSQC (135DEPT-HSQC) and heteronuclear multiple bond cor-
relation. The TOCSY experiments were performedwith aMLEV17
mixing scheme with a 100 ms spin lock (Gheysen et al., 2008).
The data are reported as follows: chemical shifts (δ), multi-
plicity (d, doublet; dd, double doublet; ddd, double double
doublet; dt, double triplet; m, multiplet; q, quartet; s, singlet;
td, triple doublet; t, triplet), coupling constants J (Hz), and
integration (Dataset 1).
Reconstitution of ClsB in S. Typhimurium ΔclsB mutant
ClsBwas isolated via PCR using forward primer 59-CGCGGATCC
GATACGGTAACGCGGTTCTTTCT-39 and reverse primer 59-GAT
GAATTCCGGCCGCAATAAAGCCGTCCAAG-39. The sequence of
the PCR product was verified by Sanger sequencing. A second
PCR was performed using forward primer 59-TAGAGGAATAAT
AAATGATGAAATGCGGCTGGCGTGAAGGTAATCAA-39 and re-
verse primer 59-GTTAGGGCTTCACTCCTGTATTTTC-39 to make
it suitable for cloning into the pBAD-TOPO vector (Life Technol-
ogies). Correct insertion was confirmed by restriction digestion
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with BsmI (New England Biolabs). A 2-ml S. Typhimurium ΔclsB
culture was grown overnight in Luria-Bertani broth (LB) with
chloramphenicol (25 µg/ml). 0.5 ml of the starter culture was
diluted in 50 ml LB with CM. This culture was incubated for 2.5 h
at 37°C while shaking. The culture was washed three times with
ice-cold 10% glycerol and used for electroporation by adding 50 ng
pBAD-TOPO-CLSB to 40 µl bacteria. A 0.1-cm cuvette was pulsed
with 1.6 kV, capacitance of 2 5 µF, for ∼5 µs. Cells were grown for
4 h in 1 ml LB without antibiotics at 37°C before plating on LB
plates with 100 µg/ml ampicillin. After overnight incubation,
colonies were picked and grown overnight in 3 ml LB with
chloramphenicol and ampicillin. Insertion of the clsB gene was
confirmed by PCR. Total lipid extraction was performed on cul-
tures of a reconstituted clone grown with or without induction
with 0.2% arabinose.
Mincle activation assay
Lipids were diluted in 20 µl isopropanol per well of a flat-bottom
96-well plate. Isopropanol was evaporated, after which 3 × 104
reporter cells in 100 µl medium were added per well. Reporter
cell lines were FcRγ-, murine Mincle and FcRγ–, or human
Mincle and FcRγ–expressing 2B4-NFAT-GFP cells (Yamasaki
et al., 2008). After 18 h at 37°C, cells were washed with PBS
1% BSA, and GFP expression was measured on the FACSCanto II
(BD). Data were analyzed using FlowJo software.
Identification of ClsB in other bacterial species
For a selection of bacterial species, the 16S sequence was
downloaded from the SILVA database (https://www.arb-silva.de).
The Alignment, Classification, and Tree service from the SILVA
server was used with default settings to align the sequences and
generate a phyologenetic tree. The unrooted tree was visualized
using the ITOL server (http://itol.embl.de/). Protein sequences
of ClsA, ClsB, and ClsC of S. Typhi were used for a BLASTP
search in bacterial genomes using the National Center for Bi-
otechnology Information server. For each Cls protein, the
percentage identity to the top hit in each bacterial species was
determined. A BLASTP search of this top hit in the S. Typhi
genome was performed to determine whether the closest hit
was the same Cls protein used in the initial BLASTP search. For
the phylogenetic analysis of Cls proteins, the amino acid se-
quences were aligned using muscle (Edgar, 2004) and infor-
mative sites selected with trimAl (Capella-Gutie´rrez et al.,
2009), and the tree (as shown in Fig. 5 b) was calculated with
MrBayes (Ronquist et al., 2012) for 1 million generations under
the mixed amino acid model and a 25% burning for consensus
tree generation; a separate calculation using iqtree (Nguyen
et al., 2015) under the automatic model selection resulted in
the same topology. Trees and input alignments are available at
https://figshare.com/s/daf0e062de746281ed52.
Synthesis of diPT
We developed a stereoselective chemical synthesis of diPT, in-
cluding de novo synthesis of a fatty acid with a 9R,10S cis-
cyclopropyl ring. The cyclopropyl fatty acid was prepared as
described by Shah et al. (2014). Briefly, rhodium-catalyzed cy-
clopropenation of octyne with ethyl diazoacetate was followed
by resolution of the enantiomers via diastereomer formation
and chromatography (Liao et al., 2004). The resulting enantio-
pure cyclopropenes were then converted to the desired enanti-
omeric fatty acids over several synthetic steps including aWittig
reaction (Coxon et al., 1999) and a diimide reduction (Smit et al.,
2008). Diacylglycerol was prepared by epoxide ring opening
(Jacobsen et al., 1997) of protected S-glycidol with palmitic acid,
followed by esterification of the resulting hydroxyl group
with the 9R,10S cyclopropyl fatty acid. Careful deprotection, to
avoid acyl shift, produced the free diacylglycerol (Fodran and
Minnaard, 2013). Suitably protected trehalose (Gilbertson and
Chang, 1995) was converted to bis-2-cyanoethyl N,N-diisopro-
pylchlorophosphoramidite and coupled with diacylglycerol,
mediated by dicyano imidazole, and then immediately followed
by oxidation to the phosphate. Finally, deprotection of the
phosphates and removal of the benzyl protecting groups pro-
vided the desired product.
Online supplemental material
Fig. S1 shows the identification of TLC-isolated lipids from S.
Typhi as hexose phospholipids. Fig. S2 shows a comparison of PT
and diPT from S. Typhi, S. Enteritidis, and S. Typhimurium. Fig.
S3 shows NMR of synthetic diPT. Table S1 lists the abundance of
PT, diPT, PE, and CL in S. Typhimurium single gene knockouts.
Table S2 lists bacterial strains and culture media. Dataset
1 shows the identification of phosphatidyltrehalose and diphos-
phatidyltrehalose from S. Typhi by NMR and quantification.
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